BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34130879)

  • 1. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.
    Lorenzo M; Palau P; Llàcer P; Domínguez E; Ventura B; Núñez G; Miñana G; Solsona J; Santas E; De La Espriella R; Bodí V; Núñez E; Sanchis J; Bayés-Genís A; Núñez J
    Eur J Intern Med; 2021 Oct; 92():94-99. PubMed ID: 34130879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
    Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
    Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length of stay and risk of very early readmission in acute heart failure.
    Miñana G; Bosch MJ; Núñez E; Mollar A; Santas E; Valero E; García-Blas S; Pellicer M; Bodí V; Chorro FJ; Sanchis J; Núñez J
    Eur J Intern Med; 2017 Jul; 42():61-66. PubMed ID: 28400077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction.
    Llàcer P; Núñez J; Manzano L; Cepeda Rodrigo JM; Salamanca Bautista P; Guzmán García M; Trullás Vila JC; Quirós López R; López Reboiro ML; Montero-Pérez-Barquero M;
    Med Clin (Barc); 2022 Aug; 159(4):164-170. PubMed ID: 34895749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
    Soler M; Miñana G; Santas E; Núñez E; de la Espriella R; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; D'Ascoli G; Marti-Cervera J; Sanchis J; Bayes-Genís A; Núñez J
    Int J Cardiol; 2020 Jun; 308():54-59. PubMed ID: 32209267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction.
    Miñana G; de la Espriella R; Palau P; Llácer P; Núñez E; Santas E; Valero E; Lorenzo M; Núñez G; Bodí V; Heredia R; Sanchis J; Bayés-Genís A; Chorro FJ; Núñez J
    Sci Rep; 2022 Jan; 12(1):1344. PubMed ID: 35079082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
    Núñez J; Bayés-Genís A; Revuelta-López E; Miñana G; Santas E; Ter Maaten JM; de la Espriella R; Carratalá A; Lorenzo M; Palau P; Llàcer P; Valle A; Bodi V; Núñez E; Lupón J; Lang C; Ng LL; Metra M; Sanchis J; Voors AA
    Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):316-324. PubMed ID: 33745912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
    Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
    JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of the left ventricular ejection fraction in patients with acute heart failure].
    Núñez J; Mainar L; Bodí V; Sanchis J; Núñez E; Miñana G; Husser O; Bosch MJ; Chorro FJ; Llàcer A
    Med Clin (Barc); 2008 Jul; 131(5):161-6. PubMed ID: 18674484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of plasma CA125 as a proxy of intra-abdominal pressure in patients with acute heart failure.
    Rubio-Gracia J; Crespo-Aznarez S; De la Espriella R; Nuñez G; Sánchez-Marteles M; Garcés-Horna V; Yanguas-Barea N; Josa-Laorden C; Cobo-Marcos M; Giménez-López I; Pérez-Calvo JI; Nuñez J
    Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(6):453-460. PubMed ID: 35512321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
    Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
    Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
    Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
    Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
    Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
    Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
    PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of carbohydrate antigen 125 in stage D heart failure.
    Zhang J; Li W; Xiao J; Hui J; Li Y
    BMC Cardiovasc Disord; 2023 Feb; 23(1):108. PubMed ID: 36841766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study.
    Akiyama E; Cinotti R; Čerlinskaitė K; Van Aelst LNL; Arrigo M; Placido R; Chouihed T; Girerd N; Zannad F; Rossignol P; Badoz M; Launay JM; Gayat E; Cohen-Solal A; Lam CSP; Testani J; Mullens W; Cotter G; Seronde MF; Mebazaa A
    ESC Heart Fail; 2020 Jun; 7(3):996-1006. PubMed ID: 32277607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients.
    Schrager J; Wheatley M; Georgiopoulou V; Osborne A; Kalogeropoulos A; Hung O; Butler J; Ross M
    Acad Emerg Med; 2013 Jun; 20(6):554-61. PubMed ID: 23758301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality.
    Reynolds K; Butler MG; Kimes TM; Rosales AG; Chan W; Nichols GA
    Am J Cardiol; 2015 Aug; 116(3):400-5. PubMed ID: 26037295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.